RecallDepth
Class II Ongoing

LOSARTAN POTASSIUM TABLETS, USP 50 mg, Bulk, Rx only, For Further Manufacturing, Packing or Repackaging only, Manufactured by: Arrow Pharma (Malta) Ltd., Birzebbugia, Malta NDC 0591-3746-00

This recall is currently active, issued April 15, 2020. It was issued by Teva Pharmaceuticals Usa.

Company
Teva Pharmaceuticals Usa
Recall Initiated
March 25, 2020
Posted
April 15, 2020
Recall Number
D-1101-2020
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Distribution

Bulk product was distributed to one re-packager in California.

Lot / Code Info

Lots 1195625A, 1195624A, 1195623A, exp. date 03/2020

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls